tiprankstipranks
Trending News
More News >
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Stock Statistics & Valuation Metrics

Compare
1,346 Followers

Total Valuation

Solid Biosciences has a market cap or net worth of $351.92M. The enterprise value is $37.79M.
Market Cap$351.92M
Enterprise Value$37.79M

Share Statistics

Solid Biosciences has 77,515,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding77,515,370
Owned by Insiders34.17%
Owned by Institutions34.96%

Financial Efficiency

Solid Biosciences’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -78.89%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-78.89%
Return on Capital Employed (ROCE)-0.82
Revenue Per Employee0.00
Profits Per Employee-1.25M
Employee Count100
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Solid Biosciences is -1.31. Solid Biosciences’s PEG ratio is -0.04.
PE Ratio-1.31
PS Ratio0.00
PB Ratio0.39
Price to Fair Value1.19
Price to FCF-2.00
Price to Operating Cash Flow-1.07
PEG Ratio-0.04

Income Statement

In the last 12 months, Solid Biosciences had revenue of 0.00 and earned -124.70M in profits. Earnings per share was -3.06.
Revenue0.00
Gross Profit0.00
Operating Income-129.73M
Pretax Income-124.70M
Net Income-124.70M
EBITDA-121.90M
Earnings Per Share (EPS)-3.06

Cash Flow

In the last 12 months, operating cash flow was -106.67M and capital expenditures -631.00K, giving a free cash flow of -107.30M billion.
Operating Cash Flow-106.67M
Free Cash Flow-107.30M
Free Cash Flow per Share-1.38

Dividends & Yields

Solid Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.80
52-Week Price Change-41.94%
50-Day Moving Average3.22
200-Day Moving Average4.98
Relative Strength Index (RSI)70.27
Average Volume (3m)1.75M

Important Dates

Solid Biosciences upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date

Financial Position

Solid Biosciences as a current ratio of 5.20, with Debt / Equity ratio of 8.02%
Current Ratio5.20
Quick Ratio5.20
Debt to Market Cap0.15
Net Debt to EBITDA0.46
Interest Coverage Ratio-381.55

Taxes

In the past 12 months, Solid Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Solid Biosciences EV to EBITDA ratio is -0.88, with an EV/FCF ratio of -1.06.
EV to Sales0.00
EV to EBITDA-0.88
EV to Free Cash Flow-1.06
EV to Operating Cash Flow-1.07

Balance Sheet

Solid Biosciences has $306.92M in cash and marketable securities with $23.63M in debt, giving a net cash position of -$283.29M billion.
Cash & Marketable Securities$306.92M
Total Debt$23.63M
Net Cash-$283.29M
Net Cash Per Share-$3.65
Tangible Book Value Per Share$3.36

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Solid Biosciences is $16.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$16.25
Price Target Upside257.93% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast
EPS Growth Forecast37.17%

Scores

Smart Score7
AI Score44
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis